Skip to main content

Table 2 Preliminary screening of single-factor Cox proportional hazard model

From: A network pharmacology approach to reveal the pharmacological targets and biological mechanism of compound kushen injection for treating pancreatic cancer based on WGCNA and in vitro experiment validation

Gene Coef Exp (coef) z P value Lower. 95 Upper. 95
MET 0.600 1.822 5.595 2.200E−08 1.476 2.247
ARNTL2 0.569 1.766 5.402 6.580E−08 1.437 2.171
TLE2 − 0.698 0.498 − 5.176 2.270E−07 0.382 0.648
FAM83A 0.202 1.224 5.041 4.630E−07 1.132 1.325
KIF23 0.564 1.758 4.960 7.040E−07 1.407 2.196
ANLN 0.458 1.580 4.919 8.680E−07 1.317 1.896
LAMA3 0.412 1.510 4.877 1.080E−06 1.279 1.781
NUSAP1 0.671 1.957 4.805 1.550E−06 1.488 2.573
TSPOAP1 − 0.400 0.670 − 4.784 1.720E−06 0.569 0.790
ECT2 0.590 1.805 4.775 1.800E−06 1.416 2.300
FAM111B 0.617 1.854 4.763 1.910E−06 1.438 2.390
ANO1 0.520 1.682 4.740 2.130E−06 1.357 2.086
CKAP2L 0.525 1.690 4.739 2.150E−06 1.360 2.100
CEP55 0.517 1.677 4.690 2.730E−06 1.351 2.081
ADGRG6 0.437 1.548 4.686 2.780E−06 1.289 1.858
CA12 0.278 1.321 4.683 2.830E−06 1.176 1.484
DLGAP5 0.507 1.660 4.665 3.090E−06 1.342 2.054
DEPDC1 0.423 1.527 4.614 3.940E−06 1.276 1.828
EREG 0.205 1.227 4.610 4.030E−06 1.125 1.339
MMP28 0.397 1.488 4.601 4.210E−06 1.256 1.762
TPX2 0.457 1.580 4.587 4.500E−06 1.299 1.920
CENPE 0.600 1.822 4.585 4.540E−06 1.410 2.355
INPP4B 0.543 1.722 4.566 4.970E−06 1.363 2.174
GPR87 0.188 1.207 4.566 4.980E−06 1.113 1.309